Stay updated on Orlistat Adjuvant in Obesity: Clinical Trial
Sign up to get notified when there's something new on the Orlistat Adjuvant in Obesity: Clinical Trial page.

Latest updates to the Orlistat Adjuvant in Obesity: Clinical Trial page
- Check5 days agoChange DetectedAdded a Locations section with Rio Grande do Sul and São Paulo locations. Updated the page revision to v3.3.3.SummaryDifference0.4%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2. This is a minor frontend update that does not affect study data or content.SummaryDifference0.1%

- Check33 days agoChange DetectedThe funding-status notice at the top of the page was removed. The study details and layout remain the same.SummaryDifference0.4%

- Check56 days agoChange DetectedOnly visual and layout updates are visible in the new screenshot; the study details, eligibility criteria, locations, and outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check77 days agoChange DetectedMajor change: updated operating status notice and version to v3.2.0, replacing v3.1.0; outlines funding lapse effects and where to check details.SummaryDifference7%

- Check84 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.SummaryDifference0.8%

Stay in the know with updates to Orlistat Adjuvant in Obesity: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Orlistat Adjuvant in Obesity: Clinical Trial page.